Mobile Lung Cancer Screening

Participants undergo a low-dose chest CT scan to screen for early lung cancer and assess associated conditions (emphysema, coronary calcifications, osteoporosis).

Assessment of lung function through spirometry, with optional plethysmography and diffusion testing to detect COPD and PRISM patterns.

Cardiovascular risk is evaluated using SCORE2/SCORE2-OP tools, based on blood pressure and cholesterol levels.

Active smokers receive a structured smoking cessation intervention, including a baseline consultation and up to two follow-up sessions (which may be remote).

Optional collection of blood and exhaled breath condensate for future analysis of biomarkers in lung cancer detection.